top of page
앵커 1

Communication


Prof. Jae-Hyung Park and Dong-kyu Cho selected as regular members of KAST
The Korean Academy of Science and Technology announced on the 20th that it had elected 28 full members for the year 2023 at the '2022 2nd...
Nov 20, 2022


The 'stem cell' challenge continues in the 'osteoarthritis' treatment market
[Medigate News Reporter Seo Min-ji] Although the number of patients with degenerative arthritis increases worldwide every year due to the...
Sep 27, 2022
Exostemtech applied for phase 1 clinical trial IND in Korea for an exosome-based osteoarthritis trea
"EST-P-EXO1" aims to regenerate damaged cartilage tissue and suppress pain Bio-venture Exostemtech has applied for the domestic clinical...
Apr 21, 2022


Daewoong Pharmaceutical and ExostemTech, joint development agreement for exosome treatment
Daewoong's 'DW-MSC' exosome extraction, purification and joint development of new indications Daewoong Pharmaceutical will join hands...
Jan 6, 2022
[Jump-Up Bio] Exostemtech said, "The first clinical trial in Korea next year...He's even going to ge
[Anchor comment] Today's JumpUp Bio introduces Exostemtech, which develops stem cell exosome treatments. It aims to enter clinical trials...
Nov 19, 2021
bottom of page
